Log in

DermTech News Headlines (NASDAQ:DMTK)

$11.13
+0.23 (+2.11 %)
(As of 03/31/2020 03:25 AM ET)
Today's Range
$10.65
Now: $11.13
$12.43
50-Day Range
$8.98
MA: $12.72
$15.98
52-Week Range
$4.52
Now: $11.13
$23.24
Volume37,332 shs
Average Volume57,598 shs
Market Capitalization$165.21 million
P/E RatioN/A
Dividend YieldN/A
Beta0.81

Headlines

DermTech (NASDAQ DMTK) News Headlines

Source:
DateHeadline
Analyzing DermTech (NASDAQ:DMTK) & Castle Biosciences (NASDAQ:CSTL)Analyzing DermTech (NASDAQ:DMTK) & Castle Biosciences (NASDAQ:CSTL)
www.americanbankingnews.com - March 29 at 6:56 PM
DermTech Announces Response to COVID-19DermTech Announces Response to COVID-19
finance.yahoo.com - March 25 at 1:15 PM
DermTech (NASDAQ:DMTK) Earns Buy Rating from Lake Street CapitalDermTech (NASDAQ:DMTK) Earns Buy Rating from Lake Street Capital
www.americanbankingnews.com - March 17 at 10:12 AM
New Study Shows Combining TERT Mutation Analyses With DermTech’s PLA Provides Improved Sensitivity for Detecting Melanoma With Non-invasive PatchesNew Study Shows Combining TERT Mutation Analyses With DermTech’s PLA Provides Improved Sensitivity for Detecting Melanoma With Non-invasive Patches
finance.yahoo.com - March 16 at 2:06 PM
DermTech (NASDAQ:DMTK) PT Raised to $24.00 at Lake Street CapitalDermTech (NASDAQ:DMTK) PT Raised to $24.00 at Lake Street Capital
www.americanbankingnews.com - March 11 at 12:39 PM
DermTech, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate UpdateDermTech, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - March 10 at 6:05 PM
DermTech EPS beats by $0.29, beats on revenueDermTech EPS beats by $0.29, beats on revenue
seekingalpha.com - March 10 at 4:21 PM
Fulgent Genetics (NASDAQ:FLGT) vs. DermTech (NASDAQ:DMTK) Head-To-Head ReviewFulgent Genetics (NASDAQ:FLGT) vs. DermTech (NASDAQ:DMTK) Head-To-Head Review
www.americanbankingnews.com - March 7 at 8:24 AM
Large Registry Study Demonstrates Clinicians Use DermTech’s Non-Invasive Gene Expression Testing to Improve Early Melanoma DetectionLarge Registry Study Demonstrates Clinicians Use DermTech’s Non-Invasive Gene Expression Testing to Improve Early Melanoma Detection
finance.yahoo.com - March 5 at 9:25 AM
DermTech to Participate at the 2020 BTIG Healthcare ConferenceDermTech to Participate at the 2020 BTIG Healthcare Conference
finance.yahoo.com - March 3 at 5:55 PM
DermTech up 7% on capital raiseDermTech up 7% on capital raise
seekingalpha.com - March 2 at 12:33 PM
DermTech Announces $65 Million Private PlacementDermTech Announces $65 Million Private Placement
finance.yahoo.com - March 2 at 7:36 AM
DermTech, Inc. Common Stock (DMTK) Insider ActivityDermTech, Inc. Common Stock (DMTK) Insider Activity
www.nasdaq.com - February 22 at 11:31 PM
Cowen’s Tim Manning at 2nd SPAC Roundtable: Fundamental Investor Interest in SPACs On RiseCowen’s Tim Manning at 2nd SPAC Roundtable: Fundamental Investor Interest in SPACs On Rise
finance.yahoo.com - February 10 at 6:59 PM
DermTech Enters into Commercial and Medicare Advantage Payor Coverage Contract for the Pigmented Lesion AssayDermTech Enters into Commercial and Medicare Advantage Payor Coverage Contract for the Pigmented Lesion Assay
finance.yahoo.com - January 16 at 7:26 PM
CMS Releases Final 2020 Clinical Lab Fee Schedule (CLFS) Including Pricing for DermTech’s Pigmented Lesion Assay (PLA)CMS Releases Final 2020 Clinical Lab Fee Schedule (CLFS) Including Pricing for DermTech’s Pigmented Lesion Assay (PLA)
finance.yahoo.com - January 8 at 4:11 PM
DermTech Shares Rise On Medicare Coverage For Skin Cancer Diagnostic TestDermTech Shares Rise On Medicare Coverage For Skin Cancer Diagnostic Test
www.msn.com - January 2 at 5:03 PM
DermTech’s Pigmented Lesion Assay (PLA) Receives Medicare CoverageDermTech’s Pigmented Lesion Assay (PLA) Receives Medicare Coverage
finance.yahoo.com - January 2 at 5:03 PM
DermTech up 13% premarket on Medicare coverage of PLA testDermTech up 13% premarket on Medicare coverage of PLA test
seekingalpha.com - January 2 at 9:37 AM
DermTech Further Expands Patent PortfolioDermTech Further Expands Patent Portfolio
finance.yahoo.com - December 9 at 9:05 AM
DermTech’s Test Included in Expert Panel’s Clinical Management Recommendations for Cutaneous MelanomaDermTech’s Test Included in Expert Panel’s Clinical Management Recommendations for Cutaneous Melanoma
finance.yahoo.com - December 9 at 9:05 AM
DermTech Announces Common Stock Will Continue Trading on The Nasdaq Capital Market; Warrant Delisting from The Nasdaq Capital MarketDermTech Announces Common Stock Will Continue Trading on The Nasdaq Capital Market; Warrant Delisting from The Nasdaq Capital Market
finance.yahoo.com - December 9 at 9:05 AM
DermTech Presents New Data at Fall Clinical Dermatology ConferenceDermTech Presents New Data at Fall Clinical Dermatology Conference
finance.yahoo.com - December 9 at 9:05 AM
DermTech Receives CPT® Proprietary Laboratory Assay Code from the American Medical AssociationDermTech Receives CPT® Proprietary Laboratory Assay Code from the American Medical Association
finance.yahoo.com - December 9 at 9:05 AM
DermTech to Present at Upcoming Investor ConferencesDermTech to Present at Upcoming Investor Conferences
finance.yahoo.com - December 9 at 9:05 AM
DermTech, Inc. Reports Third Quarter 2019 Financial Results and Provides Corporate UpdateDermTech, Inc. Reports Third Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - December 9 at 9:05 AM
This page was last updated on 3/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel